Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Non Operating Investment Income (2020 - 2024)

Tango Therapeutics has reported Non Operating Investment Income over the past 5 years, most recently at -$443000.0 for Q1 2024.

  • Quarterly results put Non Operating Investment Income at -$443000.0 for Q1 2024, down 129.45% from a year ago — trailing twelve months through Mar 2024 was $1.9 million (up 60.79% YoY), and the annual figure for FY2025 was -$112000.0, down 174.67%.
  • Non Operating Investment Income for Q1 2024 was -$443000.0 at Tango Therapeutics, down from $867000.0 in the prior quarter.
  • Over the last five years, Non Operating Investment Income for TNGX hit a ceiling of $1.5 million in Q1 2023 and a floor of -$2.6 million in Q1 2022.
  • Median Non Operating Investment Income over the past 5 years was -$9000.0 (2020), compared with a mean of -$17866.7.
  • Biggest five-year swings in Non Operating Investment Income: tumbled 17733.33% in 2022 and later skyrocketed 264.24% in 2023.
  • Tango Therapeutics' Non Operating Investment Income stood at -$9000.0 in 2020, then tumbled by 8288.89% to -$755000.0 in 2021, then surged by 252.45% to $1.2 million in 2022, then decreased by 24.67% to $867000.0 in 2023, then plummeted by 151.1% to -$443000.0 in 2024.
  • The last three reported values for Non Operating Investment Income were -$443000.0 (Q1 2024), $867000.0 (Q4 2023), and $836000.0 (Q3 2023) per Business Quant data.